Mark Lawler, Associate Director of Postgraduate Studies, Chair in Translational Cancer Genomics, and Professor of Digital Health at Queen’s University Belfast, shared a post on LinkedIn:
“Delighted to present to the team at UMass Chan Medical School on our work in cancer, one health, digital and innovation and explore areas of complementarity – excited about our joint potential.
Big thanks to Kathryn Ellis the ultimate networker for arranging the visit, the first of many from Queen’s University Belfast I hope”
Other articles featuring Mark Lawler on OncoDaily.